Tyra Biosciences (TYRA) News Today $9.66 -0.58 (-5.66%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$10.02 +0.36 (+3.72%) As of 03/27/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Average Price Target from AnalystsMarch 28 at 3:43 AM | americanbankingnews.comTyra Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and HighlightsMarch 27 at 4:14 PM | prnewswire.comTyra Biosciences, Inc. (NASDAQ:TYRA) Given Consensus Recommendation of "Buy" by AnalystsShares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have received a consensus recommendation of "Buy" from the six analysts that are currently covering the stock, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-March 23, 2025 | marketbeat.comVictory Capital Management Inc. Purchases 26,560 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA)Victory Capital Management Inc. boosted its position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 88.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 56,640 shares of the compaMarch 21, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.7% - Should You Sell?Tyra Biosciences (NASDAQ:TYRA) Shares Down 4.7% - Time to Sell?March 18, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Sees Large Volume Increase - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Sees Strong Trading Volume - Here's What HappenedMarch 15, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Reaches New 12-Month Low - Time to Sell?Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year Low - Here's WhyMarch 11, 2025 | marketbeat.comTyra Biosciences (TYRA) Expected to Announce Quarterly Earnings on TuesdayTyra Biosciences (NASDAQ:TYRA) will be releasing earnings before the market opens on Tuesday, March 18, Financial Modeling Prep reports.March 11, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Hits New 12-Month Low - Should You Sell?Tyra Biosciences (NASDAQ:TYRA) Hits New 1-Year Low - Should You Sell?March 6, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Sees Large Growth in Short InterestTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) was the target of a significant growth in short interest during the month of February. As of February 15th, there was short interest totalling 3,680,000 shares, a growth of 30.5% from the January 31st total of 2,820,000 shares. Approximately 11.9% of the company's shares are short sold. Based on an average trading volume of 234,600 shares, the days-to-cover ratio is presently 15.7 days.March 4, 2025 | marketbeat.com4,080,296 Shares in Tyra Biosciences, Inc. (NASDAQ:TYRA) Bought by Alta Partners Management Company L.P.Alta Partners Management Company L.P. acquired a new position in Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 4,080,296 shares of the cMarch 2, 2025 | marketbeat.comTyra Biosciences: FGFR1/2 Driven AE Data Spooked The MarketMarch 1, 2025 | seekingalpha.comTyra Biosciences (NASDAQ:TYRA) Hits New 12-Month Low - Time to Sell?Tyra Biosciences (NASDAQ:TYRA) Reaches New 1-Year Low - What's Next?February 28, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Rating of "Buy" by BrokeragesTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) has been given an average rating of "Buy" by the six research firms that are currently covering the firm, MarketBeat.com reports. Six investment analysts have rated the stock with a buy rating. The average 12 month target price among analystsFebruary 26, 2025 | marketbeat.comTyra Biosciences' (TYRA) Buy Rating Reaffirmed at HC WainwrightHC Wainwright reaffirmed a "buy" rating and issued a $30.00 target price on shares of Tyra Biosciences in a report on Tuesday.February 19, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Trading Up 6.6% - Here's WhyTyra Biosciences (NASDAQ:TYRA) Trading Up 6.6% - Here's WhyFebruary 15, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Hits New 52-Week Low - Here's WhyTyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week Low - Should You Sell?February 12, 2025 | marketbeat.comTyra Biosciences to Present at Upcoming Investor ConferencesFebruary 11, 2025 | prnewswire.comTyra Biosciences director Nina Kjellson sells $74,323 in stockFebruary 8, 2025 | msn.comInsider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells 5,401 Shares of StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Nina S. Kjellson sold 5,401 shares of the firm's stock in a transaction that occurred on Wednesday, February 5th. The stock was sold at an average price of $13.76, for a total transaction of $74,317.76. Following the transaction, the director now directly owns 443,885 shares of the company's stock, valued at $6,107,857.60. This represents a 1.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.February 7, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Hits New 52-Week Low - Should You Sell?Tyra Biosciences (NASDAQ:TYRA) Sets New 12-Month Low - Should You Sell?February 6, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Receives Consensus Recommendation of "Buy" from AnalystsTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) has received a consensus rating of "Buy" from the six ratings firms that are currently covering the company, Marketbeat reports. Six research analysts have rated the stock with a buy recommendation. The average 12-month price objective among bFebruary 1, 2025 | marketbeat.comTyra Biosciences Announces Appointment of Adele Gulfo to Board of DirectorsJanuary 31, 2025 | morningstar.comTyra Biosciences adds Adele Gulfo to boardJanuary 30, 2025 | msn.comTyra Biosciences appoints new board memberJanuary 30, 2025 | msn.comTyra Biosciences, Inc. (NASDAQ:TYRA) Director Nina S. Kjellson Sells 4,825 SharesJanuary 28, 2025 | insidertrades.comInsider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells 4,825 Shares of StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Nina S. Kjellson sold 4,825 shares of the business's stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $16.26, for a total transaction of $78,454.50. Following the completion of the transaction, the director now directly owns 3,702,595 shares in the company, valued at $60,204,194.70. This trade represents a 0.13 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link.January 27, 2025 | marketbeat.comTyra Biosciences director Nina Kjellson sells $78,466 in stockJanuary 27, 2025 | msn.comPrivate equity firms account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) ownership, while institutions account for 33%January 27, 2025 | uk.finance.yahoo.comCanaan Partners XI LLC Has $58.10 Million Stake in Tyra Biosciences, Inc. (NASDAQ:TYRA)Canaan Partners XI LLC lowered its stake in shares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Free Report) by 5.2% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 4,179,857 shares of the company's stock after selling 230,134 shares during the quJanuary 26, 2025 | marketbeat.comTyra Biosciences director Nina Kjellson sells shares worth $409,645January 23, 2025 | investing.comTyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers SymposiumJanuary 22, 2025 | prnewswire.comNina S. Kjellson Sells 3,993 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Nina S. Kjellson sold 3,993 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $16.36, for a total transaction of $65,325.48. Following the completion of the sale, the director now directly owns 3,707,420 shares of the company's stock, valued at $60,653,391.20. This trade represents a 0.11 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.January 21, 2025 | marketbeat.comTyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells $126,719.91 in StockTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) Director Nina S. Kjellson sold 7,779 shares of the company's stock in a transaction that occurred on Thursday, January 16th. The shares were sold at an average price of $16.29, for a total transaction of $126,719.91. Following the completion of the transaction, the director now owns 447,857 shares of the company's stock, valued at $7,295,590.53. This trade represents a 1.71 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.January 21, 2025 | marketbeat.comBank of America Securities Remains a Buy on Tyra Bioscience (TYRA)January 16, 2025 | markets.businessinsider.comTyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.1% - Time to Sell?Tyra Biosciences (NASDAQ:TYRA) Stock Price Down 4.1% - Time to Sell?January 16, 2025 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Up 7.9% - Here's What HappenedTyra Biosciences (NASDAQ:TYRA) Trading 7.9% Higher - Time to Buy?January 14, 2025 | marketbeat.comPositive Outlook for Tyra Bioscience Following FDA Clearance and Promising Clinical DataJanuary 13, 2025 | markets.businessinsider.comFDA Grants IND Clearance For Tyra Biosciences' TYRA-300January 12, 2025 | nasdaq.comTyra Falls on FDA NodJanuary 11, 2025 | baystreet.caTyra Biosciences: FDA clears IND application for TYRA-300January 11, 2025 | markets.businessinsider.comTyra Biosciences Receives IND Clearance from FDA to Proceed with Phase 2 Study of TYRA-300 in Non-Muscle Invasive Bladder Cancer (SURF302)January 10, 2025 | prnewswire.comUBS Initiates Coverage of Tyra Biosciences (TYRA) with Buy RecommendationJanuary 7, 2025 | msn.comTyra Biosciences initiated with a Buy at UBSJanuary 7, 2025 | markets.businessinsider.comTyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Buy" by BrokeragesShares of Tyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) have been assigned an average rating of "Buy" from the five analysts that are covering the stock, MarketBeat reports. Five research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokJanuary 7, 2025 | marketbeat.comUBS Group Initiates Coverage on Tyra Biosciences (NASDAQ:TYRA)UBS Group initiated coverage on shares of Tyra Biosciences in a research note on Tuesday. They issued a "buy" rating and a $28.00 price objective for the company.January 7, 2025 | marketbeat.comBank of America Securities Sticks to Their Buy Rating for Tyra Bioscience (TYRA)January 6, 2025 | markets.businessinsider.comTyra Biosciences, Inc. (NASDAQ:TYRA) Short Interest Up 25.9% in DecemberTyra Biosciences, Inc. (NASDAQ:TYRA - Get Free Report) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 2,530,000 shares, an increase of 25.9% from the November 30th total of 2,010,000 shares. Based on an average daily trading volume, of 328,900 shares, the days-to-cover ratio is currently 7.7 days. Currently, 8.2% of the shares of the stock are short sold.December 29, 2024 | marketbeat.comTyra Biosciences (NASDAQ:TYRA) Shares Down 4.3% - Here's WhyTyra Biosciences (NASDAQ:TYRA) Shares Down 4.3% - Here's What HappenedDecember 23, 2024 | marketbeat.comThe Take On Tyra BiosciencesDecember 17, 2024 | seekingalpha.com Remove Ads Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address TYRA Media Mentions By Week TYRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TYRA News Sentiment▼0.990.78▲Average Medical News Sentiment TYRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TYRA Articles This Week▼53▲TYRA Articles Average Week Remove Ads Get Tyra Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for TYRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BLTE News ARWR News CGON News HRMY News ARQT News JANX News TVTX News AGIO News TARS News APGE News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TYRA) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
